1
|
Xu H, Wang B, Li FY, Huang DW, Xiao Y, Wang JY. Access to 5-Methyl-5 H-naphtho[2,3- c]carbazole-8,13-dione Derivatives via Copper-Catalyzed Intramolecular Isomerization. J Org Chem 2023. [PMID: 38048162 DOI: 10.1021/acs.joc.3c01667] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/06/2023]
Abstract
Carbazole-fused quinones are important compounds for their potential pharmacological activities and photophysical properties. Here, a novel copper-catalyzed intramolecular isomerization process to access a new class of naphtho[2,3-c]carbazole-8,13-dione derivatives via a furan isomerization/γ-H elimination and β-C elimination/6π-electrocyclization/aromatization cascade is reported. Furthermore, the preliminary photophysical properties of the functional 5-methyl-5H-naphtho[2,3-c]carbazole-8,13-dione derivatives have been studied.
Collapse
Affiliation(s)
- Hong Xu
- Asymmetric Synthesis and Chiraltechnology Key Laboratory of Sichuan Province, Chengdu Institute of Organic Chemistry, Chinese Academy of Sciences, Chengdu 610041, P. R. China
- University of Chinese Academy of Sciences, Beijing 100049, P. R. China
| | - Bei Wang
- Department of Chemistry, Xihua University, Chengdu 610039, P. R. China
| | - Fu-Yu Li
- Asymmetric Synthesis and Chiraltechnology Key Laboratory of Sichuan Province, Chengdu Institute of Organic Chemistry, Chinese Academy of Sciences, Chengdu 610041, P. R. China
- University of Chinese Academy of Sciences, Beijing 100049, P. R. China
| | - Dong-Wei Huang
- Department of Chemistry, Xihua University, Chengdu 610039, P. R. China
| | - Yao Xiao
- Department of Chemistry, Xihua University, Chengdu 610039, P. R. China
| | - Ji-Yu Wang
- Asymmetric Synthesis and Chiraltechnology Key Laboratory of Sichuan Province, Chengdu Institute of Organic Chemistry, Chinese Academy of Sciences, Chengdu 610041, P. R. China
- Department of Chemistry, Xihua University, Chengdu 610039, P. R. China
| |
Collapse
|
2
|
Kumar MP, G M, Amaladass P, Manikandan C, Dhayalan V. Recent synthetic strategies for the construction of functionalized carbazoles and their heterocyclic motifs enabled by Lewis acids. RSC Adv 2023; 13:32596-32626. [PMID: 37936643 PMCID: PMC10626344 DOI: 10.1039/d3ra06396h] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2023] [Accepted: 10/25/2023] [Indexed: 11/09/2023] Open
Abstract
This article demonstrates recent innovative cascade annulation methods for preparing functionalized carbazoles and their related polyaromatic heterocyclic compounds enabled by Lewis acid catalysts. Highly substituted carbazole scaffolds were synthesized via Lewis acid mediated Friedel-Crafts arylation, electrocyclization, intramolecular cyclization, cycloaddition, C-N bond-formations, aromatization and cascade domino reactions, metal-catalyzed, iodine catalyzed reactions and multi-component reactions. This review article mainly focuses on Lewis acid-mediated recent synthetic methods to access a variety of electron-rich and electron-poor functional groups substituted carbazole frameworks in one-pot reactions. Polyaromatic carbazole and their related nitrogen-based heterocyclic compounds were found in several synthetic applications in pharma industries, energy devices, and materials sciences. Moreover, the review paper briefly summarised new synthetic strategies of carbazole preparation approaches will assist academic and pharma industries in identifying innovative protocols for producing poly-functionalized carbazoles and related highly complex heterocyclic compounds and discovering active pharmaceutical drugs or carbazole-based alkaloids and natural products.
Collapse
Affiliation(s)
- Marappan Pradeep Kumar
- Department of Chemistry, National Institute of Technology Puducherry Karaikal-609609 Union Territory Puducherry India https://vasudeva49.wixsite.com/catalysislab
| | - Mahantesh G
- Department of Chemistry, National Institute of Technology Puducherry Karaikal-609609 Union Territory Puducherry India https://vasudeva49.wixsite.com/catalysislab
| | - P Amaladass
- Department of Chemistry, Madanapalle Institute of Technology & Science Madanapalle 517325 Andhra Pradesh India
| | - Chitrarasu Manikandan
- Department of Chemistry, National Institute of Technology Puducherry Karaikal-609609 Union Territory Puducherry India https://vasudeva49.wixsite.com/catalysislab
| | - Vasudevan Dhayalan
- Department of Chemistry, National Institute of Technology Puducherry Karaikal-609609 Union Territory Puducherry India https://vasudeva49.wixsite.com/catalysislab
| |
Collapse
|
3
|
Benzi A, Lopes SMM, Nunes SCC, Giorgi G, Bianchi L, Tavani C, Pais AACC, Petrillo G, Pinho e Melo TMVD. Reactivity of ethyl nitrosoacrylate toward pyrrole, indole and pyrrolo[3,2- c]carbazole: an experimental and theoretical study. Front Chem 2023; 11:1229669. [PMID: 37614704 PMCID: PMC10443595 DOI: 10.3389/fchem.2023.1229669] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2023] [Accepted: 07/26/2023] [Indexed: 08/25/2023] Open
Abstract
Nitrosoalkenes react with 8-methyl-1,6-dihydropyrrolo[3,2-c]carbazole to give both 2- and 3-alkylated products via hetero-Diels-Alder reaction followed by the cycloadduct ring-opening. Quantum chemical calculations, at DFT level of theory, were carried out to investigate the regioselectivity of the cycloaddition of ethyl nitrosoacrylate with 1,6-dihydropyrrolo[3,2-c]carbazoles as well as with pyrrole and indole, allowing a more comprehensive analysis of the reactivity pattern of nitrosoalkenes with five-membered heterocycles. Furthermore, theoretical calculations confirmed that ethyl nitrosoacrylate reacts with these heterocycles via a LUMOheterodiene-HOMOdienophile controlled cycloaddition. The reactivity of one of the oxime-functionalized 1,6-dihydropyrrolo[3,2-c]carbazole was explored and a new hexahydropyrido[4',3':4,5]pyrrolo[3,2-c]carbazole system was obtained in high yield via a one-pot, two-step procedure.
Collapse
Affiliation(s)
- Alice Benzi
- Department of Chemistry and Industrial Chemistry, University of Genova, Genoa, Italy
| | - Susana M. M. Lopes
- Coimbra Chemistry Centre-Institute of Molecular Sciences, Department of Chemistry, University of Coimbra, Coimbra, Portugal
| | - Sandra C. C. Nunes
- Coimbra Chemistry Centre-Institute of Molecular Sciences, Department of Chemistry, University of Coimbra, Coimbra, Portugal
| | - Gianluca Giorgi
- Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Siena, Italy
| | - Lara Bianchi
- Department of Chemistry and Industrial Chemistry, University of Genova, Genoa, Italy
| | - Cinzia Tavani
- Department of Chemistry and Industrial Chemistry, University of Genova, Genoa, Italy
| | - Alberto A. C. C. Pais
- Coimbra Chemistry Centre-Institute of Molecular Sciences, Department of Chemistry, University of Coimbra, Coimbra, Portugal
| | - Giovanni Petrillo
- Department of Chemistry and Industrial Chemistry, University of Genova, Genoa, Italy
| | - Teresa M. V. D. Pinho e Melo
- Coimbra Chemistry Centre-Institute of Molecular Sciences, Department of Chemistry, University of Coimbra, Coimbra, Portugal
| |
Collapse
|
4
|
Walhekar V, Bagul C, Kumar D, Muthal A, Achaiah G, Kulkarni R. Topical advances in PIM kinases and their inhibitors: Medicinal chemistry perspectives. Biochim Biophys Acta Rev Cancer 2022; 1877:188725. [DOI: 10.1016/j.bbcan.2022.188725] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2022] [Revised: 03/21/2022] [Accepted: 03/25/2022] [Indexed: 12/28/2022]
|
5
|
Farajpour B, Alizadeh A. Recent advances in the synthesis of cyclic compounds using α,α-dicyanoolefins as versatile vinylogous nucleophiles. Org Biomol Chem 2022; 20:8366-8394. [DOI: 10.1039/d2ob01551j] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
This article provides a review of the applications of α,α-dicyanoolefins as versatile vinylogous nucleophiles in the synthesis of various cyclic compounds, covering the literature from the past 13 years.
Collapse
Affiliation(s)
- Behnaz Farajpour
- Department of Chemistry, Tarbiat Modares University, P. O. Box 14115-175, Tehran, Iran
| | - Abdolali Alizadeh
- Department of Chemistry, Tarbiat Modares University, P. O. Box 14115-175, Tehran, Iran
| |
Collapse
|
6
|
Is Emodin with Anticancer Effects Completely Innocent? Two Sides of the Coin. Cancers (Basel) 2021; 13:cancers13112733. [PMID: 34073059 PMCID: PMC8198870 DOI: 10.3390/cancers13112733] [Citation(s) in RCA: 55] [Impact Index Per Article: 18.3] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2021] [Revised: 05/25/2021] [Accepted: 05/28/2021] [Indexed: 12/12/2022] Open
Abstract
Many anticancer active compounds are known to have the capacity to destroy pathologically proliferating cancer cells in the body, as well as to destroy rapidly proliferating normal cells. Despite remarkable advances in cancer research over the past few decades, the inclusion of natural compounds in researches as potential drug candidates is becoming increasingly important. However, the perception that the natural is reliable is an issue that needs to be clarified. Among the various chemical classes of natural products, anthraquinones have many biological activities and have also been proven to exhibit a unique anticancer activity. Emodin, an anthraquinone derivative, is a natural compound found in the roots and rhizomes of many plants. The anticancer property of emodin, a broad-spectrum inhibitory agent of cancer cells, has been detailed in many biological pathways. In cancer cells, these molecular mechanisms consist of suppressing cell growth and proliferation through the attenuation of oncogenic growth signaling, such as protein kinase B (AKT), mitogen-activated protein kinase (MAPK), HER-2 tyrosine kinase, Wnt/-catenin, and phosphatidylinositol 3-kinase (PI3K). However, it is known that emodin, which shows toxicity to cancer cells, may cause kidney toxicity, hepatotoxicity, and reproductive toxicity especially at high doses and long-term use. At the same time, studies of emodin, which has poor oral bioavailability, to transform this disadvantage into an advantage with nano-carrier systems reveal that natural compounds are not always directly usable compounds. Consequently, this review aimed to shed light on the anti-proliferative and anti-carcinogenic properties of emodin, as well as its potential toxicities and the advantages of drug delivery systems on bioavailability.
Collapse
|
7
|
Ceramella J, Iacopetta D, Barbarossa A, Caruso A, Grande F, Bonomo MG, Mariconda A, Longo P, Carmela S, Sinicropi MS. Carbazole Derivatives as Kinase-Targeting Inhibitors for Cancer Treatment. Mini Rev Med Chem 2020; 20:444-465. [PMID: 31951166 DOI: 10.2174/1389557520666200117144701] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2019] [Revised: 10/01/2019] [Accepted: 10/19/2019] [Indexed: 12/11/2022]
Abstract
Protein Kinases (PKs) are a heterogeneous family of enzymes that modulate several biological pathways, including cell division, cytoskeletal rearrangement, differentiation and apoptosis. In particular, due to their crucial role during human tumorigenesis and cancer progression, PKs are ideal targets for the design and development of effective and low toxic chemotherapeutics and represent the second group of drug targets after G-protein-coupled receptors. Nowadays, several compounds have been claimed to be PKs inhibitors, and some of them, such as imatinib, erlotinib and gefitinib, have already been approved for clinical use, whereas more than 30 others are in various phases of clinical trials. Among them, some natural or synthetic carbazole-based molecules represent promising PKs inhibitors due to their capability to interfere with PK activity by different mechanisms of action including the ability to act as DNA intercalating agents, interfere with the activity of enzymes involved in DNA duplication, such as topoisomerases and telomerases, and inhibit other proteins such as cyclindependent kinases or antagonize estrogen receptors. Thus, carbazoles can be considered a promising this class of compounds to be adopted in targeted therapy of different types of cancer.
Collapse
Affiliation(s)
- Jessica Ceramella
- Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Arcavacata di Rende, (CS), Italy
| | - Domenico Iacopetta
- Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Arcavacata di Rende, (CS), Italy
| | - Alexia Barbarossa
- Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Arcavacata di Rende, (CS), Italy
| | - Anna Caruso
- Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Arcavacata di Rende, (CS), Italy
| | - Fedora Grande
- Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Arcavacata di Rende, (CS), Italy
| | | | | | - Pasquale Longo
- Department of Biology and Chemistry, University of Salerno, 84084 Fisciano, Italy
| | - Saturnino Carmela
- Department of Science, University of Basilicata, 85100 Potenza, Italy
| | - Maria Stefania Sinicropi
- Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Arcavacata di Rende, (CS), Italy
| |
Collapse
|
8
|
Banerjee S, Vivek Kumar S, Punniyamurthy T. Site-Selective Rh-Catalyzed C-7 and C-6 Dual C–H Functionalization of Indolines: Synthesis of Functionalized Pyrrolocarbazoles. J Org Chem 2020; 85:2793-2805. [DOI: 10.1021/acs.joc.9b03180] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Affiliation(s)
- Sonbidya Banerjee
- Department of Chemistry, Indian Institute of Technology Guwahati, Guwahati 781039, India
| | - Sundaravel Vivek Kumar
- Department of Chemistry, Indian Institute of Technology Guwahati, Guwahati 781039, India
| | | |
Collapse
|
9
|
Issa S, Prandina A, Bedel N, Rongved P, Yous S, Le Borgne M, Bouaziz Z. Carbazole scaffolds in cancer therapy: a review from 2012 to 2018. J Enzyme Inhib Med Chem 2019; 34:1321-1346. [PMID: 31328585 PMCID: PMC6691762 DOI: 10.1080/14756366.2019.1640692] [Citation(s) in RCA: 76] [Impact Index Per Article: 15.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023] Open
Abstract
For over half a century, the carbazole skeleton has been the key structural motif of many biologically active compounds including natural and synthetic products. Carbazoles have taken an important part in all the existing anti-cancer drugs because of their discovery from a large variety of organisms, including bacteria, fungi, plants, and animals. In this article, we specifically explored the literature from 2012 to 2018 on the anti-tumour activities reported to carbazole derivatives and we have critically collected the most significant data. The most described carbazole anti-tumour agents were classified according to their structure, starting from the tricyclic–carbazole motif to fused tetra-, penta-, hexa- and heptacyclic carbazoles. To date, three derivatives are available on the market and approved in cancer therapy.
Collapse
Affiliation(s)
- Samar Issa
- a Ecole de Biologie Industrielle, EBInnov , Cergy-Pontoise , France
| | - Anthony Prandina
- b Faculté de Pharmacie - ISPB, EA 4446 Bioactive Molecules and Medicinal Chemistry, SFR Santé Lyon-Est CNRS UMS3453 - INSERM US7, Université de Lyon, Université Claude Bernard Lyon 1 , Lyon , France.,c Department of Pharmaceutical Chemistry, School of Pharmacy, University of Oslo , Oslo , Norway
| | - Nicolas Bedel
- b Faculté de Pharmacie - ISPB, EA 4446 Bioactive Molecules and Medicinal Chemistry, SFR Santé Lyon-Est CNRS UMS3453 - INSERM US7, Université de Lyon, Université Claude Bernard Lyon 1 , Lyon , France
| | - Pål Rongved
- c Department of Pharmaceutical Chemistry, School of Pharmacy, University of Oslo , Oslo , Norway
| | - Saïd Yous
- d Université Lille, Inserm, CHU Lille, UMR-S 1172 JPArc Centre de Recherche Jean-Pierre Aubert Neurosciences et Cancer , Lille , France
| | - Marc Le Borgne
- b Faculté de Pharmacie - ISPB, EA 4446 Bioactive Molecules and Medicinal Chemistry, SFR Santé Lyon-Est CNRS UMS3453 - INSERM US7, Université de Lyon, Université Claude Bernard Lyon 1 , Lyon , France
| | - Zouhair Bouaziz
- b Faculté de Pharmacie - ISPB, EA 4446 Bioactive Molecules and Medicinal Chemistry, SFR Santé Lyon-Est CNRS UMS3453 - INSERM US7, Université de Lyon, Université Claude Bernard Lyon 1 , Lyon , France
| |
Collapse
|
10
|
Giraud F, Pereira E, Anizon F, Moreau P. Synthesis and Applications of Dihydropyrrolocarbazoles. European J Org Chem 2019. [DOI: 10.1002/ejoc.201900269] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
Affiliation(s)
- Francis Giraud
- CNRS, SIGMA Clermont, ICCF Université Clermont Auvergne 63000 Clermont‐Ferrand France
| | - Elisabeth Pereira
- CNRS, SIGMA Clermont, ICCF Université Clermont Auvergne 63000 Clermont‐Ferrand France
| | - Fabrice Anizon
- CNRS, SIGMA Clermont, ICCF Université Clermont Auvergne 63000 Clermont‐Ferrand France
| | - Pascale Moreau
- CNRS, SIGMA Clermont, ICCF Université Clermont Auvergne 63000 Clermont‐Ferrand France
| |
Collapse
|
11
|
PIM kinase inhibitors: Structural and pharmacological perspectives. Eur J Med Chem 2019; 172:95-108. [PMID: 30954777 DOI: 10.1016/j.ejmech.2019.03.050] [Citation(s) in RCA: 38] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2018] [Revised: 02/28/2019] [Accepted: 03/19/2019] [Indexed: 02/08/2023]
Abstract
The PIM kinase, also known as serine/threonine kinase plays an important role in cancer biology and is found in three different isoforms namely PIM-1, PIM-2, and PIM-3. They are extensively distributed and are implicated in a variety of biological processes, including cell proliferation, cell differentiation, and apoptosis. They act as weak oncogene and whenever expressed in exacerbating forms are responsible for different types of human cancer. Recently, different isoforms of PIM kinase have been identified as a clinical biomarker and potential therapeutic target for personalized treatment of advanced cancer. The inhibition of PIM kinase has become a scientific interest and some inhibitors have been developed and/or are under different phases of clinical trials. Several medicinally privileged heterocyclic ring scaffolds such as pyrrole, pyrimidine, thiazolidine, benzofuran, indole, triazole, oxadiazole, and quinoline derivatives have been synthesized and evaluated for their PIM inhibitory activity. This review comprehensively focuses on pharmacological implications of PIM kinases in oncogenesis, structural insights of PIM inhibitors and their structure-activity relationships (SARs).
Collapse
|
12
|
Cao D, Ying A, Mo H, Chen D, Chen G, Wang Z, Yang J. [4 + 2] Annulation of 3-Nitroindoles with Alkylidene Malononitriles: Entry to Substituted Carbazol-4-amine Derivatives. J Org Chem 2018; 83:12568-12574. [PMID: 30229658 DOI: 10.1021/acs.joc.8b01876] [Citation(s) in RCA: 28] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
A general and transition-metal-free method for the construction of the carbazol-4-amine motif via a vinylogous Michael addition/cyclization/isomerization/elimination reaction of 3-nitroindoles with alkylidene malononitriles has been developed. This novel methodology allows the facile synthesis of a series of di- and trisubstituted carbazol-4-amine derivatives in moderate to good yields. A gram-scale experiment was successfully performed, highlighting the practicability of this method. Moreover, this strategy is also applicable to 3-nitrobenzothiophene, affording the corresponding dibenzo[ b, d]thiophen-1-amine derivatives in moderate yields.
Collapse
Affiliation(s)
- Dongdong Cao
- School of Pharmaceutical and Chemical Engineering , Taizhou University , Taizhou 318000 , P.R. China
| | - Anguo Ying
- School of Pharmaceutical and Chemical Engineering , Taizhou University , Taizhou 318000 , P.R. China
| | - Hanjie Mo
- School of Pharmaceutical and Chemical Engineering , Taizhou University , Taizhou 318000 , P.R. China
| | - Dingben Chen
- School of Pharmaceutical and Chemical Engineering , Taizhou University , Taizhou 318000 , P.R. China
| | - Gang Chen
- School of Pharmaceutical and Chemical Engineering , Taizhou University , Taizhou 318000 , P.R. China
| | - Zhiming Wang
- College of Pharmaceutical Science , Zhejiang Chinese Medical University , Hangzhou 311400 , P.R. China
| | - Jianguo Yang
- School of Pharmaceutical and Chemical Engineering , Taizhou University , Taizhou 318000 , P.R. China
| |
Collapse
|
13
|
Effect of fluorinated tetrahydrocarbazole derivatives on the enzymes of oxidative deamination of biogenic amines and on the process of lipid peroxidation. Russ Chem Bull 2017. [DOI: 10.1007/s11172-017-1821-9] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
14
|
Lamera E, Bouacida S, Le Borgne M, Bouaziz Z, Bouraiou A. Sequential MCR/Fisher indolization strategy for the construction of polycyclic carbazole derivatives. Tetrahedron Lett 2017. [DOI: 10.1016/j.tetlet.2017.02.047] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
15
|
Synthesis and biological activity of pyrazole analogues of the staurosporine aglycon K252c. Bioorg Med Chem 2016; 24:3116-24. [DOI: 10.1016/j.bmc.2016.05.032] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2016] [Revised: 05/13/2016] [Accepted: 05/17/2016] [Indexed: 01/20/2023]
|
16
|
Identification of novel inhibitors for Pim-1 kinase using pharmacophore modeling based on a novel method for selecting pharmacophore generation subsets. J Comput Aided Mol Des 2015; 30:39-68. [PMID: 26685860 DOI: 10.1007/s10822-015-9887-7] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2015] [Accepted: 12/07/2015] [Indexed: 10/22/2022]
Abstract
Targeting Proviral integration-site of murine Moloney leukemia virus 1 kinase, hereafter called Pim-1 kinase, is a promising strategy for treating different kinds of human cancer. Headed for this a total list of 328 formerly reported Pim-1 kinase inhibitors has been explored and divided based on the pharmacophoric features of the most active molecules into 10 subsets projected to represent potential active binding manners accessible to ligands within the binding pocket of Pim-1 kinase. Discovery Studio 4.1 (DS 4.1) was employed to detect potential pharmacophoric active binding manners anticipated by Pim-1 Kinase inhibitors. The pharmacophoric models were then allowed to compete within Quantitative Structure Activity Relationship (QSAR) framework with other 2D descriptors. Accordingly Genetic algorithm and multiple linear regression investigation were engaged to find the finest QSAR equation that has the best predictive power r262(2) = 0.70, F = 119.14, rLOO(2) = 0.693, rPRESS(2) against 66 external test inhibitors = 0.71 q(2) = 0.55. Three different pharmacophores appeared in the successful QSAR equation this represents three different binding modes for inhibitors within the Pim-1 kinase binding pocket. Pharmacophoric models were later used to screen compounds within the National Cancer Institute database. Several low micromolar Pim-1 Kinase inhibitors were captured. The most potent hits show IC50 values of 0.77 and 1.03 µM. Also, upon analyzing the successful QSAR Equation we found that some polycyclic aromatic electron-rich structures namely 6-Chloro-2-methoxy-acridine can be considered as putative hits for Pim-1 kinase inhibition.
Collapse
|
17
|
Abstract
Carbazoles represent an important class of heterocycles. These have been reported to exhibit diverse biological activities such as antimicrobial, antitumor, antiepileptic, antihistaminic, antioxidative, anti-inflammatory, antidiarrhoeal, analgesic, neuroprotective and pancreatic lipase inhibition properties. A series of carbazole derivatives such as N-substituted carbazoles, benzocarbazoles, furocarbazoles, pyrrolocarbazoles, indolocarbazoles, imidazocarbazoles, etc. have been synthesized. The N-substituted derivatives have gained the attention of researchers due to their therapeutic potential against neurological disorders and cell proliferation. Herein an attempt is made to review the medicinal importance of recently synthesized N-substituted carbazoles.
Collapse
|
18
|
Wurz RP, Pettus LH, Jackson C, Wu B, Wang HL, Herberich B, Cee V, Lanman BA, Reed AB, Chavez F, Nixey T, Laszlo J, Wang P, Nguyen Y, Sastri C, Guerrero N, Winston J, Lipford JR, Lee MR, Andrews KL, Mohr C, Xu Y, Zhou Y, Reid DL, Tasker AS. The discovery and optimization of aminooxadiazoles as potent Pim kinase inhibitors. Bioorg Med Chem Lett 2015; 25:847-55. [DOI: 10.1016/j.bmcl.2014.12.067] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2014] [Revised: 12/16/2014] [Accepted: 12/19/2014] [Indexed: 11/26/2022]
|
19
|
Prakash K, Nagarajan R. Copper-catalyzed heteroannulation: a simple route to the synthesis of pyrrolo[2,3-b]carbazole and pyrrolo[2,3-b]quinoline derivatives. Tetrahedron Lett 2015. [DOI: 10.1016/j.tetlet.2014.10.070] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
20
|
Suchaud V, Gavara L, Giraud F, Nauton L, Théry V, Anizon F, Moreau P. Synthesis of pyrazolo[4,3-a]phenanthridines, a new scaffold for Pim kinase inhibition. Bioorg Med Chem 2014; 22:4704-10. [DOI: 10.1016/j.bmc.2014.07.011] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2014] [Revised: 07/07/2014] [Accepted: 07/08/2014] [Indexed: 11/30/2022]
|
21
|
Bouaziz Z, Issa S, Gentili J, Gratz A, Bollacke A, Kassack M, Jose J, Herfindal L, Gausdal G, Døskeland SO, Mullié C, Sonnet P, Desgrouas C, Taudon N, Valdameri G, Di Pietro A, Baitiche M, Le Borgne M. Biologically active carbazole derivatives: focus on oxazinocarbazoles and related compounds. J Enzyme Inhib Med Chem 2014; 30:180-8. [DOI: 10.3109/14756366.2014.899594] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023] Open
Affiliation(s)
- Zouhair Bouaziz
- EA 4446 Biomolécules Cancer et Chimiorésistances, Faculté de Pharmacie - ISPB, Université Lyon 1, Lyon, France,
| | - Samar Issa
- Ecole de Biologie Industrielle, EBInnov, Cergy-Pontoise, France,
| | - Jacques Gentili
- EA 4446 Biomolécules Cancer et Chimiorésistances, Faculté de Pharmacie - ISPB, Université Lyon 1, Lyon, France,
| | | | | | | | - Joachim Jose
- IPMC, PharmaCampus, WWU Münster, Germany,
- IPMC, Heinrich-Heine-Universität Düsseldorf, Germany,
| | - Lars Herfindal
- Department of Biomedicine, University of Bergen, Norway,
- Translational Signaling Group, Haukeland University Hospital, Bergen, Norway,
| | - Gro Gausdal
- Department of Biomedicine, University of Bergen, Norway,
| | | | - Catherine Mullié
- Laboratoire de Glycochimie, des Antimicrobiens et des Agroressources (LG2A), FRE-CNRS 3517, Université de Picardie Jules Verne, Amiens, France,
| | - Pascal Sonnet
- Laboratoire de Glycochimie, des Antimicrobiens et des Agroressources (LG2A), FRE-CNRS 3517, Université de Picardie Jules Verne, Amiens, France,
| | - Camille Desgrouas
- UMR-MD3, Faculté de pharmacie, Aix-Marseille-Université, Marseille, France,
| | - Nicolas Taudon
- UMR-MD3, Faculté de pharmacie, Aix-Marseille-Université, Marseille, France,
| | - Glaucio Valdameri
- Drug Resistance Mechanism and Modulation Group, Bases Moléculaires et Structurales des Systèmes Infectieux (BMSSI), UMR 5086, CNRS, Université Lyon 1, IBCP, Lyon, France,
- Department of Biochemistry and Molecular Biology, UFPR, Curitiba, Brazil, and
| | - Attilio Di Pietro
- Drug Resistance Mechanism and Modulation Group, Bases Moléculaires et Structurales des Systèmes Infectieux (BMSSI), UMR 5086, CNRS, Université Lyon 1, IBCP, Lyon, France,
| | | | - Marc Le Borgne
- EA 4446 Biomolécules Cancer et Chimiorésistances, Faculté de Pharmacie - ISPB, Université Lyon 1, Lyon, France,
| |
Collapse
|
22
|
Suchaud V, Gavara L, Saugues E, Nauton L, Théry V, Anizon F, Moreau P. Identification of 1,6-dihydropyrazolo[4,3-c]carbazoles and 3,6-dihydropyrazolo[3,4-c]carbazoles as new Pim kinase inhibitors. Bioorg Med Chem 2013; 21:4102-11. [PMID: 23735828 DOI: 10.1016/j.bmc.2013.05.011] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2013] [Revised: 05/06/2013] [Accepted: 05/08/2013] [Indexed: 12/14/2022]
Abstract
New 1,6-dihydropyrazolo[4,3-c]carbazoles and 3,6-dihydropyrazolo[3,4-c]carbazoles were prepared and evaluated for their Pim kinase inhibitory potencies as well as their antiproliferative activities toward two prostatic cancer cell lines. Pyrazolocarbazole 15a was found to be a potent Pim kinase modulator with inhibitory potency toward the three isoforms. Compound 6c strongly inhibited Pim-3 with weaker effect toward Pim-1 and Pim-2, and thus could be used as an interesting molecular tool to study Pim-3 biological functions.
Collapse
Affiliation(s)
- Virginie Suchaud
- Clermont Université, Université Blaise Pascal, Institut de Chimie de Clermont-Ferrand, BP 10448, 63000 Clermont-Ferrand, France
| | | | | | | | | | | | | |
Collapse
|
23
|
Identification of pyrrolo[2,3-g]indazoles as new Pim kinase inhibitors. Bioorg Med Chem Lett 2013; 23:2298-301. [PMID: 23499503 DOI: 10.1016/j.bmcl.2013.02.074] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2013] [Revised: 02/12/2013] [Accepted: 02/14/2013] [Indexed: 12/14/2022]
Abstract
The synthesis and Pim kinase inhibition potency of a new series of pyrrolo[2,3-g]indazole derivatives is described. The results obtained in this preliminary structure-activity relationship study pointed out that sub-micromolar Pim-1 and Pim-3 inhibitory potencies could be obtained in this series, more particularly for compounds 10 and 20, showing that pyrrolo[2,3-g]indazole scaffold could be used for the development of new potent Pim kinase inhibitors. Molecular modeling experiments were also performed to study the binding mode of these compounds in Pim-3 ATP-binding pocket.
Collapse
|